Results 71 to 80 of about 1,561,331 (181)

Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents. [PDF]

Tremor Other Hyperkinet Mov (N Y), 2022
Kannarkat GT, Caroff SN, Morley JF.
europepmc   +1 more source

Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents. [PDF]

Brain Sci, 2023
Habiba U, Malik A, Raja GK, Memon MR, Nizami ATD, Ishaq R, Ilyas M, Valadi H, Nawaz M, Shaiq PA.   +9 more
europepmc   +1 more source

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

, 2005
Some antipsychotic agents have been indicated as a possible risk factor for venous thromboembolism (VTE) in adult patients with psychiatric disorders. The aim of this study was to estimate the effect of atypical and conventional antipsychotic agents on ...
Kate L. Lapane, Bernabei, Roberto, Giovanni Gambassi, Roberto Bernabei, Pedone, Claudio, Liperoti, Rosa, Gambassi, Giovanni, Rosa Liperoti, Claudio Pedone, Vincent Mor   +9 more
core   +1 more source

Association between antipsychotic agents and risk of lung cancer: a nested case-control study. [PDF]

Cancer Commun (Lond), 2022
Li J, Tang F, Si S, Xue F.
europepmc   +1 more source

Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis. [PDF]

Curr Neuropharmacol, 2023
Yang M, Wang C, Zhao G, Kong D, Liu L, Yuan S, Chen W, Feng C, Li Z.   +8 more
europepmc   +1 more source

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database. [PDF]

Int Clin Psychopharmacol, 2023
Kane JM, Chen A, Lim S, Mychaskiw MA, Tian M, Wang Y, Suett M, Rubio JM.   +7 more
europepmc   +1 more source

Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia

, 2018
Background: Tardive dyskinesia (TD) is a disabling movement disorder associated with the prolonged use of antipsychotic medication. Several strategies have been examined in the treatment of TD.
Rathbone, John, Hanna Bergman, Karla Soares-Weiser, Bergman, Hanna, El-Sayeh, Hany G., Hany G El-Sayeh, El-Sayeh, Hany G, John Rathbone, Soares-Weiser, Karla   +8 more
core   +1 more source

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia. [PDF]

Ther Adv Psychopharmacol, 2022
Ma CH, Chan HY, Hsieh MH, Liu CC, Liu CM, Hwu HG, Kuo CH, Chen WJ, Hwang TJ.   +8 more
europepmc   +1 more source

[Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review]. [PDF]

Nervenarzt, 2023
Leopold S, Quante A.
europepmc   +1 more source

Prolactin monitoring for patients on antipsychotic drugs: A narrative review of clinical relevance [PDF]

© 2025 The Authors. Published by Scientific Scholar on behalf of Archives of Biological Psychiatry. This is an open access article available under a Creative Commons licence.
Kar, Nilamadhab, Cook, Natalie
core   +1 more source